International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released Mar 30, 2023, after the close
10-K filed Mar 30, 2023, 89 days after period end · 0000950170-23-010977
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $2.43M | $1.84M | $1.48M | $2.84M |
| Net Income | $23.00K | -$351.00K |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| -$721.00K |
| -$2.71M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
